Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Testosterone therapy tested in prostate cancer patients – a risky move?

NCT ID NCT07278362

First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 18 times

Summary

This study looks at whether testosterone replacement therapy is safe for men who have both low-risk prostate cancer and low testosterone, and are under active surveillance. Researchers will track if the cancer gets worse within 12 months. The goal is to see if this treatment can be used without causing harm.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Desai Sethi Urology Institute

    Miami, Florida, 33136, United States

    Contact

  • Sylvester Comprehensive Cancer Center

    Miami, Florida, 33136, United States

    Contact

Conditions

Explore the condition pages connected to this study.